VALERIE SCOTT: Open Payments
NPI 1710969795 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,338 in 75 payments from 18 companies in 2025. Trend: 2023 $2,084 · 2024 $2,339 · 2025 $1,338
Food & beverage: $1,338
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $244 |
| UCB, Inc. | 9 | $196 |
| Novartis Pharmaceuticals Corporation | 16 | $165 |
| ABBVIE INC. | 7 | $150 |
| GlaxoSmithKline, LLC. | 7 | $110 |
| ANI Pharmaceuticals, Inc. | 4 | $101 |
| Janssen Biotech, Inc. | 3 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Corcept Therapeutics | 2 | $41 |
| GENZYME CORPORATION | 1 | $40 |
Products named: Bimzelx, COSENTYX, RINVOQ, BENLYSTA, PURIFIED CORTROPHIN GEL, TREMFYA, EVENITY, OTEZLA.
Industry payments across LA — which companies pay providers there.
